139 related articles for article (PubMed ID: 19403168)
1. Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.
Ding L; Wang HX; Xue M; Zhu L; Liu J; Yan HM; Duan LN; Wang ZD
Leuk Res; 2009 Sep; 33(9):e170-2. PubMed ID: 19403168
[No Abstract] [Full Text] [Related]
2. Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.
Santoro A; Magagnoli M; Spina M; Pinotti G; Siracusano L; Michieli M; Nozza A; Sarina B; Morenghi E; Castagna L; Tirelli U; Balzarotti M
Haematologica; 2007 Jan; 92(1):35-41. PubMed ID: 17229633
[TBL] [Abstract][Full Text] [Related]
3. B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).
Balzarotti M; Brusamolino E; Angelucci E; Carella AM; Vitolo U; Russo E; Congiu A; Gotti M; Massidda S; Botto B; Annechini G; Spina M; Re A; Zilioli VR; Merli F; Salvi F; Stelitano C; Bonfichi M; Rodari M; Murru R; Magagnoli M; Anastasia A; Mazza R; Giordano L; Santoro A
Leuk Lymphoma; 2016 Oct; 57(10):2375-81. PubMed ID: 26879066
[TBL] [Abstract][Full Text] [Related]
4. Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on (18)F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma.
Fallanca F; Picchio M; Crivellaro C; Mapelli P; Samanes Gajate AM; Sabattini E; Gianolli L; Messa C
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):207-9. PubMed ID: 22980128
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Mian M; Farsad M; Pescosta N; Casini M; Cavattoni IM; Deola S; Cortelazzo S
Ann Hematol; 2013 Jan; 92(1):121-3. PubMed ID: 22820997
[No Abstract] [Full Text] [Related]
6. High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.
Cocorocchio E; Peccatori F; Vanazzi A; Piperno G; Calabrese L; Botteri E; Travaini L; Preda L; Martinelli G
Hematol Oncol; 2013 Mar; 31(1):34-40. PubMed ID: 22473680
[TBL] [Abstract][Full Text] [Related]
7. A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.
Horton TM; Drachtman RA; Chen L; Cole PD; McCarten K; Voss S; Guillerman RP; Buxton A; Howard SC; Hogan SM; Sheehan AM; López-Terrada D; Mrazek MD; Agrawal N; Wu MF; Liu H; De Alarcon PA; Trippet TM; Schwartz CL
Br J Haematol; 2015 Jul; 170(1):118-22. PubMed ID: 25833390
[TBL] [Abstract][Full Text] [Related]
8. IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.
Magagnoli M; Spina M; Balzarotti M; Timofeeva I; Isa L; Michieli M; Capizzuto R; Morenghi E; Castagna L; Tirelli U; Santoro A
Bone Marrow Transplant; 2007 Dec; 40(11):1019-25. PubMed ID: 17906705
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.
Mendler JH; Kelly J; Voci S; Marquis D; Rich L; Rossi RM; Bernstein SH; Jordan CT; Liesveld J; Fisher RI; Friedberg JW
Ann Oncol; 2008 Oct; 19(10):1759-64. PubMed ID: 18504251
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.
Ozkaynak MF; Jayabose S
Pediatr Hematol Oncol; 2004 Mar; 21(2):107-13. PubMed ID: 15160509
[TBL] [Abstract][Full Text] [Related]
11. Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.
Santoro A; Mazza R; Pulsoni A; Re A; Bonfichi M; Zilioli VR; Salvi F; Merli F; Anastasia A; Luminari S; Annechini G; Gotti M; Peli A; Liberati AM; Di Renzo N; Castagna L; Giordano L; Carlo-Stella C
J Clin Oncol; 2016 Sep; 34(27):3293-9. PubMed ID: 27382096
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
Di Renzo N; Brugiatelli M; Montanini A; Vigliotti ML; Cervetti G; Liberati AM; Luminari S; Spedini P; Giglio G; Federico M
Leuk Lymphoma; 2006 Mar; 47(3):473-9. PubMed ID: 16396771
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT.
Suyanı E; Sucak GT; Akı ŞZ; Yeğin ZA; Özkurt ZN; Yağcı M
Ann Hematol; 2011 Jun; 90(6):685-91. PubMed ID: 21072518
[TBL] [Abstract][Full Text] [Related]
14. Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement.
Capalbo S; Chiefa A; Delia M; Diomede D; Liso V
Acta Oncol; 2007; 46(2):262-4. PubMed ID: 17453381
[No Abstract] [Full Text] [Related]
15. A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.
Farid M; Yau YW; Tay K; Quek R; Tao M; Koo GC; Loong S; Lim ST
Acta Oncol; 2011 May; 50(4):589-90. PubMed ID: 21226543
[No Abstract] [Full Text] [Related]
16. Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.
Chen JH; Chang PY; Yao NS
Hematol Oncol Stem Cell Ther; 2009; 2(2):371-2. PubMed ID: 20118065
[No Abstract] [Full Text] [Related]
17. Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.
Castagna L; Magagnoli M; Balzarotti M; Sarina B; Siracusano L; Nozza A; Todisco E; Bramanti S; Mazza R; Russo F; Timofeeva I; Santoro A
Am J Hematol; 2007 Feb; 82(2):122-7. PubMed ID: 17019686
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma.
Marr K; Ronsley R; Nadel H; Douglas K; Gershony S; Strahlendorf C; Davis JH; Deyell RJ
Pediatr Blood Cancer; 2020 Apr; 67(4):e28167. PubMed ID: 31925920
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.
Arai S; Letsinger R; Wong RM; Johnston LJ; Laport GG; Lowsky R; Miklos DB; Shizuru JA; Weng WK; Lavori PW; Blume KG; Negrin RS; Horning SJ
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1145-54. PubMed ID: 20197102
[TBL] [Abstract][Full Text] [Related]
20. A multicentre phase-II feasibility study evaluating gemcitabine/vinorelbine / prednisolone combination chemotherapy in relapsed / refractory Hodgkin's lymphoma.
Naqi N; Ahmad S; Shah I; Khattak J
J Coll Physicians Surg Pak; 2013 Jun; 23(6):397-400. PubMed ID: 23763798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
